91 related articles for article (PubMed ID: 31135968)
1. A time-resolved live cell imaging assay to identify small molecule inhibitors of FGF2 signaling.
Ahmed M; Legrand C; Yagüe Relimpio A; Beretta CA; Muschko A; Wegehingel S; Müller HM; Sehr P; Will DW; Lewis JD; Nickel W
FEBS Lett; 2019 Aug; 593(16):2162-2176. PubMed ID: 31135968
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 2 mRNA expression evoked by amitriptyline involves extracellular signal-regulated kinase-dependent early growth response 1 production in rat primary cultured astrocytes.
Kajitani N; Hisaoka-Nakashima K; Okada-Tsuchioka M; Hosoi M; Yokoe T; Morioka N; Nakata Y; Takebayashi M
J Neurochem; 2015 Oct; 135(1):27-37. PubMed ID: 26183033
[TBL] [Abstract][Full Text] [Related]
3. Ligand concentration is a driver of divergent signaling and pleiotropic cellular responses to FGF.
Garcia-Maya M; Anderson AA; Kendal CE; Kenny AV; Edwards-Ingram LC; Holladay A; Saffell JL
J Cell Physiol; 2006 Feb; 206(2):386-93. PubMed ID: 16155940
[TBL] [Abstract][Full Text] [Related]
4. Retina regeneration in the chick embryo is not induced by spontaneous Mitf downregulation but requires FGF/FGFR/MEK/Erk dependent upregulation of Pax6.
Spence JR; Madhavan M; Aycinena JC; Del Rio-Tsonis K
Mol Vis; 2007 Jan; 13():57-65. PubMed ID: 17277739
[TBL] [Abstract][Full Text] [Related]
5. Novel multiple tyrosine kinase inhibitor ponatinib inhibits bFGF-activated signaling in neuroblastoma cells and suppresses neuroblastoma growth in vivo.
Li H; Wang Y; Chen Z; Lu J; Pan J; Yu Y; Zhao Y; Zhang H; Hu T; Liu Q; Yang J
Oncotarget; 2017 Jan; 8(4):5874-5884. PubMed ID: 27564113
[TBL] [Abstract][Full Text] [Related]
6. ERK1/2 and JNK signaling synergistically modulate mitogenic effect of fibroblast growth factor 2 on liver cell.
Wu S; Zhang W; Ma S; Li B; Xu C; Yi P
Cell Biol Int; 2018 Nov; 42(11):1511-1522. PubMed ID: 30080297
[TBL] [Abstract][Full Text] [Related]
7. Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adipose-derived stem cells.
Zaragosi LE; Ailhaud G; Dani C
Stem Cells; 2006 Nov; 24(11):2412-9. PubMed ID: 16840552
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor-2 is an important factor that maintains cellular immaturity and contributes to aggressiveness of osteosarcoma.
Shimizu T; Ishikawa T; Iwai S; Ueki A; Sugihara E; Onishi N; Kuninaka S; Miyamoto T; Toyama Y; Ijiri H; Mori H; Matsuzaki Y; Yaguchi T; Nishio H; Kawakami Y; Ikeda Y; Saya H
Mol Cancer Res; 2012 Mar; 10(3):454-68. PubMed ID: 22228819
[TBL] [Abstract][Full Text] [Related]
9. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J
Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma.
Maehara O; Suda G; Natsuizaka M; Ohnishi S; Komatsu Y; Sato F; Nakai M; Sho T; Morikawa K; Ogawa K; Shimazaki T; Kimura M; Asano A; Fujimoto Y; Ohashi S; Kagawa S; Kinugasa H; Naganuma S; Whelan KA; Nakagawa H; Nakagawa K; Takeda H; Sakamoto N
Carcinogenesis; 2017 Oct; 38(11):1073-1083. PubMed ID: 28927233
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cell proliferation and apoptosis in neuroblastoma cells by ccp1, a FGF2 downstream gene.
Pellicano F; Thomson RE; Inman GJ; Iwata T
BMC Cancer; 2010 Nov; 10():657. PubMed ID: 21118521
[TBL] [Abstract][Full Text] [Related]
12. Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts.
Tanghetti E; Ria R; Dell'Era P; Urbinati C; Rusnati M; Ennas MG; Presta M
Oncogene; 2002 May; 21(24):3889-97. PubMed ID: 12032827
[TBL] [Abstract][Full Text] [Related]
13. FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells.
Krejci P; Bryja V; Pachernik J; Hampl A; Pogue R; Mekikian P; Wilcox WR
Exp Cell Res; 2004 Jul; 297(1):152-64. PubMed ID: 15194433
[TBL] [Abstract][Full Text] [Related]
14. FGF2 binding, signaling, and angiogenesis are modulated by heparanase in metastatic melanoma cells.
Reiland J; Kempf D; Roy M; Denkins Y; Marchetti D
Neoplasia; 2006 Jul; 8(7):596-606. PubMed ID: 16867222
[TBL] [Abstract][Full Text] [Related]
15. Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis.
Krejci P; Masri B; Fontaine V; Mekikian PB; Weis M; Prats H; Wilcox WR
J Cell Sci; 2005 Nov; 118(Pt 21):5089-100. PubMed ID: 16234329
[TBL] [Abstract][Full Text] [Related]
16. Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis.
Dell'Era P; Mohammadi M; Presta M
Mol Biol Cell; 1999 Jan; 10(1):23-33. PubMed ID: 9880324
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells.
Kim MS; Kim CJ; Jung HS; Seo MR; Juhnn YS; Shin HY; Ahn HS; Thiele CJ; Chi JG
J Pathol; 2004 Jan; 202(1):103-12. PubMed ID: 14694527
[TBL] [Abstract][Full Text] [Related]
18. Simple, mammalian cell-based assay for identification of inhibitors of the Erk MAP kinase pathway.
Krejci P; Pejchalova K; Wilcox WR
Invest New Drugs; 2007 Aug; 25(4):391-5. PubMed ID: 17458503
[TBL] [Abstract][Full Text] [Related]
19. Small Molecule Inhibitors Targeting Tec Kinase Block Unconventional Secretion of Fibroblast Growth Factor 2.
La Venuta G; Wegehingel S; Sehr P; Müller HM; Dimou E; Steringer JP; Grotwinkel M; Hentze N; Mayer MP; Will DW; Uhrig U; Lewis JD; Nickel W
J Biol Chem; 2016 Aug; 291(34):17787-803. PubMed ID: 27382052
[TBL] [Abstract][Full Text] [Related]
20. Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist.
Alessi P; Leali D; Camozzi M; Cantelmo A; Albini A; Presta M
Eur Cytokine Netw; 2009 Dec; 20(4):225-34. PubMed ID: 20167562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
